PMV Pharmaceuticals Statistics

Total Valuation

PMVP has a market cap or net worth of $63.32 million. The enterprise value is -$65.00 million.

Market Cap	63.32M
Enterprise Value	-65.00M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

PMVP has 53.21 million shares outstanding. The number of shares has increased by 1.41% in one year.

Current Share Class	53.21M
Shares Outstanding	53.21M
Shares Change (YoY)	+1.41%
Shares Change (QoQ)	+1.89%
Owned by Insiders (%)	3.38%
Owned by Institutions (%)	49.29%
Float	41.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.52
P/TBV Ratio	0.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.76, with a Debt / Equity ratio of 0.01.

Current Ratio	10.76
Quick Ratio	10.50
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.87% and return on invested capital (ROIC) is -34.35%.

Return on Equity (ROE)	-51.87%
Return on Assets (ROA)	-32.02%
Return on Invested Capital (ROIC)	-34.35%
Return on Capital Employed (ROCE)	-75.31%
Revenue Per Employee	n/a
Profits Per Employee	-$1.76M
Employee Count	47
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.20M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.17% in the last 52 weeks. The beta is 1.64, so PMVP's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	-29.17%
50-Day Moving Average	1.39
200-Day Moving Average	1.24
Relative Strength Index (RSI)	35.87
Average Volume (20 Days)	245,897

Short Selling Information

The latest short interest is 1.53 million, so 2.88% of the outstanding shares have been sold short.

Short Interest	1.53M
Short Previous Month	1.52M
Short % of Shares Out	2.88%
Short % of Float	3.73%
Short Ratio (days to cover)	2.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.54M
Pretax Income	-84.90M
Net Income	-82.71M
EBITDA	-91.40M
EBIT	-91.54M
Earnings Per Share (EPS)	-$1.58

Full Income Statement

Balance Sheet

The company has $129.25 million in cash and $931,000 in debt, giving a net cash position of $128.32 million or $2.41 per share.

Cash & Cash Equivalents	129.25M
Total Debt	931,000
Net Cash	128.32M
Net Cash Per Share	$2.41
Equity (Book Value)	121.00M
Book Value Per Share	2.28
Working Capital	120.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.05 million and capital expenditures -$70,000, giving a free cash flow of -$73.12 million.

Operating Cash Flow	-73.05M
Capital Expenditures	-70,000
Free Cash Flow	-73.12M
FCF Per Share	-$1.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMVP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.41%
Shareholder Yield	-1.41%
Earnings Yield	-130.61%
FCF Yield	-115.47%

Analyst Forecast

The average price target for PMVP is $5.00, which is 320.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	320.17%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-6.67%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1